N. Gupta

发表

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Siddharth Singh, B. Sands, C. Siegel, 2018, The American Journal of Gastroenterology.

Cirrhotic patients with large esophageal varices and older age have poor hemodynamic response to terlipressin.

S. Sarin, Ashish Kumar, Praveen Sharma, 2015, European journal of gastroenterology & hepatology.

Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension.

B. Sharma, S. Sarin, A. Agrawal, 2010, Gastroenterology.

Tamsulosin facilitates earlier clearance of stone fragments and reduces pain after shockwave lithotripsy for renal calculi: results from an open-label randomized study.

M. Agarwal, A. Mandal, Santosh Kumar, 2008, Urology.

Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohn's Disease Activity

M. Ciorba, W. Stenson, T. Riehl, 2012, Inflammatory bowel diseases.

Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis.

Shakil Ahmed Khan, R. Khan, A. Sharma, 2018, Clinica chimica acta; international journal of clinical chemistry.

Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial

B. Sharma, S. Sarin, Ashish Kumar, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

Siddharth Singh, B. Sands, C. Siegel, 2019, Inflammatory bowel diseases.

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.

Siddharth Singh, B. Sands, C. Siegel, 2018, Inflammatory bowel diseases.

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

Siddharth Singh, B. Sands, C. Siegel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Siddharth Singh, B. Sands, C. Siegel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Valacyclovir in the treatment of acute retinal necrosis

S. Lightman, R. Hamilton, Jiten Morarji, 2012, BMC Ophthalmology.

Fracture of the penis: a radiological or clinical diagnosis? A case series and literature review.

M. Agarwal, A. Mandal, Santosh Kumar, 2009, The Canadian journal of urology.

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

John T. Chang, Siddharth Singh, B. Sands, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis

B. Sands, C. Siegel, W. Sandborn, 2018 .

277 - Comparative Safety Profile of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy for Inflammatory Bowel Disease: A Multicenter Consortium Propensity Score-Matched Analysis

Siddharth Singh, B. Sands, C. Siegel, 2018 .

OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis

B. Sands, C. Siegel, W. Sandborn, 2018 .

DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis

C. Siegel, W. Sandborn, E. Loftus, 2018 .

Sa1723 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Crohn's Disease: A Multicenter Consortium Propensity Score-Matched Analysis

Siddharth Singh, B. Sands, C. Siegel, 2018 .

A REVIEW ON 'BIOMARKERS' AS DIAGNOSTIC TOOL Review Article

S. Nagar, N. Gupta, K. Kinja, 2011 .

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Siddharth Singh, B. Sands, C. Siegel, 2018, The American Journal of Gastroenterology.

Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohn's Disease Activity

M. Ciorba, W. Stenson, T. Riehl, 2012, Inflammatory bowel diseases.

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Siddharth Singh, B. Sands, C. Siegel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

328 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Ulcerative Colitis: A Multicenter Consortium Propensity Score-Matched Analysis

Siddharth Singh, B. Sands, C. Siegel, 2018 .